Trials / Recruiting
RecruitingNCT05392712
Magnetocardiography in the Accurate Identification of Severe Coronary Lesions and Myocardial Necrosis
Ultra-sensitive Magnetocardiography in the Accurate Identification of Severe Coronary Lesions and Myocardial Necrosis
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 430 (estimated)
- Sponsor
- Qilu Hospital of Shandong University · Academic / Other
- Sex
- All
- Age
- 18 Years – 79 Years
- Healthy volunteers
- Accepted
Summary
Magnetocardiography (MCG) is a promising noninvasive and accurate method for detecting myocardial ischemia. Although progress has been made in this area, there is a lack of studies using up-to-date examination instruments for the calibration of MCG analysis. This is a prospective single-center study aiming to build accurate analytical models of MCG to detect coronary lesions and myocardial necrosis. Coronary lesions are measured by coronary angiography (CAG) or coronary CTA, and are defined by both the stenosis degree and the computer-simulated fraction flow reserve. Myocardial necrosis is examined and quantified by cardiac MR. Healthy volunteers, chest pain patients who will receive CAG or CTA examination, and patients with acute myocardial infarction will be enrolled in this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Magnetometer | inspection equipment for magnetocardiography |
Timeline
- Start date
- 2022-05-30
- Primary completion
- 2024-08-30
- Completion
- 2024-12-30
- First posted
- 2022-05-26
- Last updated
- 2024-08-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05392712. Inclusion in this directory is not an endorsement.